tiprankstipranks
Trending News
More News >
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Balance Sheet

Compare
438 Followers

TransCode Therapeutics Balance Sheet

TransCode Therapeutics's total assets for Q3 2025 were $5.23M, a decrease of -36.77% from the previous quarter. RNAZ total liabilities were $3.80M for the fiscal quarter, a 79.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Mar 24Dec 22Mar 22Dec 20
Total Assets
$ 7.29M$ 5.17M$ 7.59M$ 22.94M$ 1.06M
Total Liabilities
$ 9.31M$ 3.53M$ 4.35M$ 2.53M$ 4.46M
Total Equity Gross Minority
$ -2.02M$ 1.64M$ 3.24M$ 20.40M$ -3.41M
Other Metrics
Currency in USD

TransCode Therapeutics Debt to Assets